NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 388 filers reported holding NEKTAR THERAPEUTICS in Q3 2018. The put-call ratio across all filers is 0.59 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $446,000 | -40.4% | 24,486 | +16.4% | 0.01% | -40.0% |
| Q2 2019 | $748,000 | -21.1% | 21,032 | -25.5% | 0.02% | -21.1% |
| Q1 2019 | $948,000 | -69.8% | 28,226 | -70.4% | 0.02% | -74.0% |
| Q4 2018 | $3,135,000 | -33.4% | 95,370 | +23.5% | 0.07% | -21.5% |
| Q3 2018 | $4,706,000 | +984.3% | 77,198 | +768.6% | 0.09% | +933.3% |
| Q2 2018 | $434,000 | -63.9% | 8,888 | -50.4% | 0.01% | -30.8% |
| Q1 2018 | $1,203,000 | +33.5% | 17,930 | +18.8% | 0.01% | -35.0% |
| Q4 2017 | $901,000 | +200.3% | 15,092 | +20.6% | 0.02% | +185.7% |
| Q3 2017 | $300,000 | +41.5% | 12,518 | +15.7% | 0.01% | +40.0% |
| Q2 2017 | $212,000 | +46.2% | 10,824 | +75.7% | 0.01% | +25.0% |
| Q1 2017 | $145,000 | +113.2% | 6,160 | +11.1% | 0.00% | +100.0% |
| Q4 2016 | $68,000 | – | 5,544 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TIRSCHWELL & LOEWY INC | 588,908 | $7,138,000 | 1.23% |
| Granahan Investment Management | 3,693,956 | $44,771,000 | 1.21% |
| NEA Management Company, LLC | 1,825,600 | $22,126,000 | 1.09% |
| FIC CAPITAL INC | 150,868 | $1,829,000 | 0.75% |
| Rhenman & Partners Asset Management AB | 181,797 | $2,203,000 | 0.66% |
| SOPHROSYNE CAPITAL LLC | 60,200 | $728,000 | 0.64% |
| HARVEY CAPITAL MANAGEMENT INC | 130,400 | $1,580,000 | 0.63% |
| Artal Group S.A. | 1,300,000 | $15,756,000 | 0.57% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 564,418 | $6,840,000 | 0.47% |
| OppenheimerFunds, Inc. | 24,400,000 | $295,728,000 | 0.35% |